529 related articles for article (PubMed ID: 10833090)
41. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
42. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
[TBL] [Abstract][Full Text] [Related]
44. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Chan FK; Sung JJ; Suen R; Wu JC; Ling TK; Chung SC
Aliment Pharmacol Ther; 2000 Jan; 14(1):91-5. PubMed ID: 10632651
[TBL] [Abstract][Full Text] [Related]
45. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Wu CJ; Hsu PI; Lo GH; Lo CC; Lin CK; Shie CB; Peng NJ; Tseng HH; Jou HS; Tsai PM; Chen A; Chen JL; Lai KH
J Chin Med Assoc; 2004 Apr; 67(4):161-7. PubMed ID: 15244013
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
[TBL] [Abstract][Full Text] [Related]
47. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
48. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
49. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
[TBL] [Abstract][Full Text] [Related]
50. Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Dammann HG; Fölsch UR; Hahn EG; von Kleist DH; Klör HU; Kirchner T; Strobel S; Kist M
Helicobacter; 2000 Mar; 5(1):41-51. PubMed ID: 10672051
[TBL] [Abstract][Full Text] [Related]
51. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
53. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
Cammarota G; Papa A; Cianci R; Cannizzaro O; Armuzzi A; Gasbarrini A; Addolorato G; Gasbarrini GB
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):247-50. PubMed ID: 10333196
[TBL] [Abstract][Full Text] [Related]
54. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Yukselen V; Yasa MH; Karaoglu AO
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
[TBL] [Abstract][Full Text] [Related]
55. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
56. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
57. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
58. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Adamek RJ; Pfaffenbach B; Szymanski C
Helicobacter; 1998 Sep; 3(3):206-11. PubMed ID: 9731993
[TBL] [Abstract][Full Text] [Related]
59. Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
Catalano F; Catanzaro R; Branciforte G; Bentivegna C; Cipolla R; Brogna A; Nuciforo G
J Clin Gastroenterol; 2000 Sep; 31(2):130-6. PubMed ID: 10993428
[TBL] [Abstract][Full Text] [Related]
60. [Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Gisbert JP; Boixeda D; Bermejo F; Moreno L; Ramos F; Martín de Argila C; García Arata I; García Plaza A
Rev Clin Esp; 1998 Oct; 198(10):655-9. PubMed ID: 9844453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
